71P Discontinuation of immune checkpoint inhibitors for reasons other than disease progression and the impact on relapse and survival of advanced melanoma patients: A systematic review and meta-analysis
K. Lallas , E. Chatziioannou , D. Durak , G. Frey , L.M. Serna Higuita , M-L. Rasch , A. Kyrgidis , Z. Apalla , U. Leiter-Stoppke , L. Flatz , A. Lallas , T.M.S. Amaral
{"title":"71P Discontinuation of immune checkpoint inhibitors for reasons other than disease progression and the impact on relapse and survival of advanced melanoma patients: A systematic review and meta-analysis","authors":"K. Lallas , E. Chatziioannou , D. Durak , G. Frey , L.M. Serna Higuita , M-L. Rasch , A. Kyrgidis , Z. Apalla , U. Leiter-Stoppke , L. Flatz , A. Lallas , T.M.S. Amaral","doi":"10.1016/j.iotech.2024.100814","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100814"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immuno-oncology technology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590018824001114","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
